| Spirig HealthCare AG - Esomeprazol Spirig HC 10 mg, magensaftresistentes Granulat zur Herstellung einer Suspension zum Einnehmen | | 70596 | | 01 | | Esomeprazol Spirig HC 10 mg | | magensaftresistentes Granulat zur Herstellung einer Suspension zum Einnehmen | | A02BC05 | | Esomeprazol | | 29.04.2026 | | |
| | Composition | | esomeprazolum 10 mg ut esomeprazolum magnesicum, sacchari sphaerae corresp. saccharum max. 4 mg, ethylcellulosum, magnesii stearas, povidonum K 90, magnesii oxidum leve, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, triethylis citras, glyceroli monostearas 40-55, polysorbatum 80, talcum, glucosum monohydricum 2.8 g, xanthani gummi, crospovidonum, E 172 (flavum), hydroxypropylcellulosum, acidum citricum monohydricum, silica colloidalis anhydrica, ad granulatum pro charta. | | Packungsbestandteile | | magensaftresistentes Granulat zur Herstellung einer Suspension zum Einnehmen | | | | | | Principe actif | Concentr. |
|---|
| Esomeprazol | 10 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Acidi Methacrylici | | | | Acide Citrique Monohydre | | | | Ad Granulatum | | | | Crospovidonum | | | | E 172 | | color. | | Ethylcellulosum | | | | Ethylis Acrylatis Polymerisatum Dispersio | 30 | | | Glucose Monohydrate | 2.8 g | | | Glyceroli Monostearas | 40-55 | | | Hydroxypropylcellulosum | | | | Magnesii Oxidum Leve | | | | Magnesii Stearas | | | | Per Centum | | | | Polysorbatum 80 | | | | Povidonum K | 90 | | | Sacchari Sphaerae | | | | Silica Colloidalis Anhydrica | | | | Talcum | | | | Triethylis Citras | | | | Xanthani Gummi | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 28 | | | B | | Non |
|
|
